Actively Recruiting
Randomized Trial of Shenfu Injection to Prevent and Treat Ventilator Dependence and Diaphragm Dysfunction in Critically Ill Adults
Led by The Fourth Affiliated Hospital of Zhejiang University School of Medicine · Updated on 2026-10-19
400
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating the use of Shenfu Injection to prevent and treat ventilator dependence and ventilator-induced diaphragm dysfunction VIDD in critically ill adults receiving invasive mechanical ventilation. This randomized controlled trial compares Shenfu Injection plus standard care to placebo plus standard care, aiming to assess whether Shenfu Injection can improve diaphragm function and help patients successfully wean off mechanical ventilation. Participants are divided into groups for prevention or treatment. In the prevention group, Shenfu Injection or placebo is given twice daily after more than 24 hours of mechanical ventilation until successful weaning. In the treatment group, participants with established ventilator dependence receive the injection or placebo twice daily for 10 days, along with ventilator-weaning training starting on Day 3 that gradually increases daily until liberation from ventilation for over 48 hours. Throughout the study, diaphragm function is monitored daily using bedside ultrasound to measure diaphragm movement and thickness. Clinical outcomes include the rate and timing of successful weaning and whether mechanical ventilation must be resumed within 48 hours after initial weaning. Participants receive regular assessments during treatment to evaluate these measures, with the trial expected to conclude in August 2027.
CONDITIONS
Brief Title
Shenfu Injection for the Prevention and Treatment of Ventilator Dependence in Mechanically Ventilated Patients
Research Team
M
Min Li
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here